🔗 Permalink

Inventor profile of:

Steven H. Olson

City:

Millbrae, California

Country:

United States

Published Applications:

Last publication date:

2026-03-19

Top Assignees for applications by Steven H. Olson

The entities that hold a legal rights for patent applications filed by inventor Olson Steven H.:

Amgen Inc. 19 Thousand Oaks, CA United States
Teijin Pharma Limited 1 Tokyo, Japan

Recent patent applications by Olson Steven H.

Steven H. Olson from Millbrae, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-03-19

US20260078091A1

Chemistry; metallurgy

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

#2 | 2024-09-12

US20240300892A1

Chemistry; metallurgy

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

#3 | 2022-06-02

US20220169611A1

Chemistry; metallurgy

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

#4 | 2021-06-17

US20210179560A1

Chemistry; metallurgy

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

#5 | 2019-09-12

US20190275008A1

Human necessities

Triazole furan compounds as agonists of the APJ receptor

#6 | 2019-02-28

US20190062276A1

Chemistry; metallurgy

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

#7 | 2018-12-13

US20180354918A1

Chemistry; metallurgy

CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer

#8 | 2018-11-08

US20180319773A1

Chemistry; metallurgy

Triazole agonists of the APJ receptor

#9 | 2018-08-09

US20180222895A1

Chemistry; metallurgy

Compounds for use in preparing heterocyclic triazole agonists of the APJ receptor

#10 | 2017-11-09

US20170320860A1

Chemistry; metallurgy

Heterocyclic triazole compounds as agonists of the APJ receptor

#11 | 2017-05-25

US20170144971A1

Chemistry; metallurgy

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

#12 | 2017-02-16

US20170044131A1

Chemistry; metallurgy

Methods for preparing triazole agonists of the APJ receptor

#13 | 2017-02-16

US20170042897A1

Human necessities

Intermediates for preparing triazole agonists of the APJ receptor

#14 | 2017-02-16

US20170042872A1

Human necessities

Triazole agonists of the APJ receptor

#15 | 2017-02-16

US20170042871A1

Human necessities

Triazole agonists of the APJ receptor

#16 | 2017-02-09

US20170037026A1

Chemistry; metallurgy

Triazole agonists of the APJ receptor

#17 | 2017-02-09

US20170035744A1

Human necessities

Intermediates for preparing triazole agonists of the APJ receptor

#18 | 2016-11-24

US20160340336A1

Chemistry; metallurgy

Triazole agonists of the APJ receptor

#19 | 2016-05-19

US20160137667A1

Chemistry; metallurgy

Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer

#20 | 2016-02-11

US20160039774A1

Chemistry; metallurgy

Heteroaryl acid morpholinone compounds as MDM2 inhibitors for the treatment of cancer

#21 | 2016-01-07

US20160002185A1

Chemistry; metallurgy

CIS-MORPHOLINONE AND OTHER COMPOUNDS AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER

#22 | 2015-09-24

US20150266824A1

Chemistry; metallurgy

Pyrazole amide derivative

#23 | 2014-10-23

US20140315895A1

Chemistry; metallurgy

Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer

#24 | 2014-08-21

US20140235629A1

Chemistry; metallurgy

Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer

InventorID:

880978 ⎘